News | May 05, 2023
India is emerging as a favourable destination to conduct clinical trials: PwC-USAIC Report
Biopharma can benefit from the critical enablers of innovation in the private healthcare system in India
Biopharma can benefit from the critical enablers of innovation in the private healthcare system in India
The Research by Indian Fellow at the University has major implications for neurodegenerative disease treatments
Lebrikizumab is an investigational high-affinity and potent IL-13 inhibitor being studied in adult and adolescent patients
Cipla has recently signed an agreement to make and market the diabetes therapy Galvus and its combination brands in India from 01 January 2026.
The New State-of-Art OligoPilot 2000 solid-phase synthesizer adds cGMP manufacturing capacity to support and accelerate clinical and commercial oligonucleotide programs.
Bayer reported the highest market capitalization growth of 23.1% during Q1 2023
The company will set up a MRI, CT Scan, Sonography- Ultrasound, X-Ray Center and Pathology Lab
The blood test market worldwide is today around $75-80 billion
Prometheus Biosciences’ comprehensive data set enables target discovery and precision medicine approach in inflammation and immunology
MoU signed between AIIA and University of Amrita Vishwa Vidhyapeetham for collaboration in the field of Research and Academics in Ayurveda
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
